F-Star Therapeutics Inc
NASDAQ:FSTX
F-Star Therapeutics Inc
Net Issuance of Common Stock
F-Star Therapeutics Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
F-Star Therapeutics Inc
NASDAQ:FSTX
|
Net Issuance of Common Stock
$78.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-18%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$719m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$288.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is F-Star Therapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
78.3m
USD
Based on the financial report for Dec 31, 2021, F-Star Therapeutics Inc's Net Issuance of Common Stock amounts to 78.3m USD.
What is F-Star Therapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
22%
Over the last year, the Net Issuance of Common Stock growth was 422%. The average annual Net Issuance of Common Stock growth rates for F-Star Therapeutics Inc have been 24% over the past three years , 22% over the past five years .